Effects of hormone replacement therapy alone or in combination with alendronate on bone mineral density of woman with osteoporosis

Journal Title: Przegląd Menopauzalny - Year 2005, Vol 22, Issue 6

Abstract

Hormone replacement therapy (HRT) alone as well as bisphosphanates alone are effective treatment for postmenopausal osteoporosis but the effect of multi-drugs treatment is not well recognized. The aim of the study was to compare HRT, and its combination with alendronate (ALE) on bone mineral density (BMD) in postmenopausal women with osteoporosis. Materials and Methods: A total of 90 patients with osteoporosis, who had not been receiving HRT for at least 1 year were randomized to receive 1 mg 17b-estradiol plus 0.5 mg 19-norethisterone acetate daily, per os (n=45; Group I), or in combination with ALE in a dose 10 mg/d (HRT+ALE; n=45; Group II), for 1 year. BMD of the lumbar spine was measured using QCT at baseline and after 1 year of treatment. Each group were divided into 2 subgroups depend on the T score values: A – 2.5 or less at the lumbar spine (n=37); B – higher than –2.5 in patients with additional risk factors (n=8). Results: At the end of one year treatment, increases in spinal BMD were found in all examined groups but statistically significant on combined therapy. Compared with HRT alone, ALE+HRT produced significantly greater increases in BMD of the lumbar spine [T score ALE+HRT vs HRT – Group A 8.26% vs 5.78% (NS); Group B 13.8% vs 10.18% (NS) or BMD – Group A 3,24% vs 1.40% (NS); Grupa B 3.35% vs 0.74% (NS) ]. Conclusion: The combination of HRT and ALE in postmenopausal women with osteoporosis did not offer an extra gain of BMD over treatment of HRT alone.

Authors and Affiliations

Ewa Karzewnik

Keywords

Related Articles

Influence of HRT on cardiovascular diseases - review of literature

In the article authors discuss the influence of HRT (hormonal replacement therapy) and ERT (estrogen replacement therapy) on frequency of cardiovascular events. There are controversies between conclusions from studies: o...

Go red for women

Cardiovascular disease (CVD) is the most common cause of death in both men and women. Clinical and epidemiologic studies have shown differences among women and men with CVD in disease processes, clinical presentations an...

The case of using antiangiogenic agent - plasmide vector psFLT and radiochemioterapy in locally advanced vulvar cancer

This is a case report documenting a successful use of antiangiogenic agent- plasmide vector psFLT with successive chemo-radiotherapy and radical surgery in patient with primarily unoperable invasive carcinoma of the vulv...

Stres, objawy i przekonania dotyczące menopauzy a obniżony nastrój u kobiet w wieku 45–55 lat. Próba weryfikacji zmodyfikowanego psychospołecznego modelu depresji w okresie okołomenopauzalnym

Cel pracy: W artykule przedstawiono wyniki badań nad uwarunkowaniami obniżonego nastroju u kobiet w wieku okołomenopauzalnym. Podstawą teoretyczną badań była zmodyfikowana wersja psychospołecznego modelu depresji menopa...

The role of E-selectin in inflammatory and atherogenic processes - the impact of hormonal therapy of the menopausal period

E-selectin plays a very important role in phlogistic and atherosclerotic processes of the human organism. Expression of this membrane protein is found on inflammatory endothelial cells as a result of the action of pro-...

Download PDF file
  • EP ID EP82328
  • DOI -
  • Views 61
  • Downloads 0

How To Cite

Ewa Karzewnik (2005). Effects of hormone replacement therapy alone or in combination with alendronate on bone mineral density of woman with osteoporosis. Przegląd Menopauzalny, 22(6), 10-16. https://europub.co.uk/articles/-A-82328